Zealand Pharma A/S Receivables

Zealand Pharma A/S (ZLDPF) currently reports a receivables of $3.9B as of June 2026. That compares with $180M in the prior-year period — up 2048.9% year over year. Use the charts on this page to explore Zealand Pharma A/S's receivables history and peer comparisons.

Zealand Pharma A/S's receivables increased from $180M to $3.9B — a 2048.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zealand Pharma A/S reported $3.9B in receivables as of June 2026. That compares with $180M in the prior-year period — up 2048.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $3.9B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zealand Pharma A/S, and consider following ZLDPF for alerts when major investors trade the stock.

Zealand Pharma A/S is classified in the Healthcare sector. On receivables, it currently shows $3.9B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZLDPF with unrelated industries.